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Abstract
Primary ciliary dyskinesia (PCD) is a rare, autosomal recessive, genetically heterogeneous
disorder characterized by ciliary dysfunction resulting in chronic oto-sino-pulmonary disease,
respiratory distress in term neonates, laterality (situs) defects, and bronchiectasis. Diagnosis has
traditionally relied on ciliary ultrastructural abnormalities seen by electron microscopy. Mutations
in radial spoke head proteins occur in PCD patients with central apparatus defects. Advances in
genetic testing have been crucial in addressing the diagnostic challenge. Here, we describe a novel
splice-site mutation (c.921+3_6delAAGT) in RSPH4A, which leads to a premature translation
termination signal in nine subjects with PCD (seven families). Loss-of-function was confirmed
with quantitative ciliary ultrastructural analysis, measurement of ciliary beat frequency and
waveform, and transcript analysis. All nine individuals carrying c.921+3_6delAAGT splice-site
mutation in RSPH4A were Hispanic with ancestry tracing to Puerto Rico. This mutation is a
founder mutation and a common cause of PCD without situs abnormalities in patients of Puerto
Rican descent.
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Primary ciliary dyskinesia (PCD; MIM# 244400) (http://www.ncbi.nlm.nih.gov/Omim/) is a
rare, autosomal recessive, genetically heterogeneous disorder manifested by ciliary
dysfunction, which causes respiratory distress in term neonates, laterality (situs) defects,
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otitis media, sinusitis, bronchiectasis, and male infertility (Barbato et al., 2009; Leigh et al.,
2009; Noone et al., 2004; Zariwala et al., 2013; Zariwala et al., 2007). The test to confirm
the diagnosis of PCD has traditionally been based on identifying ciliary ultrastructural
abnormalities using electron microscopy. However, we now know that at least one-third of
PCD patients have normal ciliary ultrastructure based on a characteristic clinical phenotype,
(Knowles et al., 2012; Zariwala et al., 2013) diminished production of nasal nitric oxide
(nNO) (<100 nl/min versus ~300 nl/min for controls), and recent advances in genetic testing
(Barbato et al., 2009; Knowles et al., 2012; Leigh et al., 2009; Noone et al., 2004; Zariwala
et al., 2013).
Definition of the molecular (genetic) pathophysiology of PCD is challenging because of the
genetic heterogeneity and the complexities of cilia structure and function. Motile cilia in the
respiratory tract extend from the cellular membrane from the basal body, which is a special
derivative of the centriole (Zariwala et al., 2007). An outer ring of 9 microtubular doublets
connected by nexin links surround a central pair of microtubules (9+2 axonemal structure)
(Figure 1A). Inner and outer dynein arms extend from the central pair to the outer doublets
and contain ATPases that provide motive force for bending of the cilia (Zariwala et al.,
2007). Radial spokes, similar to spokes on a bicycle wheel, extend from the outer doublets
to the central pair and provide support for the axonemal structure. Mutations affecting any
part of ciliary biogenesis, structure, or activity can cause impaired function, which can
manifests as inadequate mucociliary clearance, upper and lower airway disease, and
dysmotile sperm. The specialized motile cilia at the embryonic node does not have the
central pair of microtubules (9+0 axonemal structure); therefore, altered left-right placement
of organs during embryogenesis does not occur with radial spokes mutations, but does occur
with mutations in components of the 9 microtubular doublets or dynein arms (Barbato et al.,
2009; Leigh et al., 2009; Zariwala et al., 2013; Zariwala et al., 2007).
Genetic testing is now becoming useful to address the diagnostic challenge in PCD. There
are currently 19 genes known to harbor PCD-causing mutations, accounting for two-thirds
of PCD cases (Horani et al., 2012; Knowles et al., 2013; Kott et al., 2012; Wirschell et al.,
2013; Zariwala et al., 2013). The majority of diagnosed PCD cases reflect defects in the
outer dynein arm (ODA) and result from mutations in DNAH5 (MIM# 603335) and DNAI1
(MIM# 604366) (Leigh et al., 2009; Zariwala et al., 2007). There is emerging recognition
that mutations in genes encoding cytoplasmic proteins involved in assembling axonemal
components (dynein axonemal assembly factors; DNAAF) lead to loss of both outer and
inner dynein arms of cilia (Horani et al., 2012; Kott et al., 2012; Zariwala et al., 2013). Most
cases of PCD with defects in the inner dynein arms (IDA) also have microtubular
disorganization and reflect mutations in CCDC39 (MIM# 613798) and CCDC40 (MIM#
613799) (Antony et al., 2012). Mutations in radial spoke head genes RSPH4A (MIM#
612647) and RSPH9 (MIM# 612648) occur in PCD patients with normal IDA and ODAs,
but approximately half of the cilia have defects in the central apparatus (Castleman et al.,
2009; Zietkiewicz et al., 2012).
We performed genetic studies in patients evaluated at UNC and collaborating sites under the
auspices of the Genetic Disorders of Mucociliary Clearance Consortium (GDMCC) (http://
rarediseasesnetwork.epi.usf.edu/gdmcc/index.htm), which is studying rare genetic disorders
of mucociliary clearance. Study subjects were evaluated by a detailed history, physical
exam, chest radiographic studies, and measurements of nasal nitric oxide (nNO) (Noone et
al., 2004). Electron microscopy (EM) of nasal epithelial samples obtained by scrape biopsy
of the inferior turbinate was performed, and images were evaluated at UNC through a
standardized protocol and blinded review of more than 20 cilia images per subject (Knowles
et al., 2012; Noone et al., 2004). Ciliary beat frequency and waveform were assessed and
analyzed by standard methods (Knowles et al., 2012; Zhou et al., 2009).
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Thirty-six PCD patients were selected to test for RSPH4A (NM_001010892.2) mutations.
All patients had clinical phenotype consistent with PCD, low nNO (<100 nl/min), and EM
images that were normal and/or had a subset of cilia with central apparatus abnormalities
(Supp. Table S1). Ages ranged from 2 to 63 years and one third of patients were male. Situs
abnormalities were present in 5 patients. Twenty-two had normal ciliary EMs, 12 had central
apparatus abnormalities with normal dynein arms, and 2 did not have EMs. The average
nasal NO value was 26.9 nl/min +/− 23.1 (mean+/−).
Genomic DNA was extracted either from peripheral blood, lymphoblastoid cell lines or
buccal swabs (Noone et al., 2004; Zariwala et al., 2001). Mutation profiling was carried out
for all 6 coding exons and splice junctions in RSPH4A, using gene specific primers from the
flanking introns (Supp. Table S2). 10–100 ng of genomic DNA was used for amplification
using the reagents and cycle conditions as previously reported (Zariwala et al., 2001;
Knowles et al., 2012). Reagents and thermal cycler used were from Life Technologies
(Carlsbad, CA). Successfully amplified products were subjected to bidirectional Sanger
sequencing using gene specific primers and Prism BigDye primer Cycle Sequencing Ready
Reaction kit (Life Technologies, Carlsbad, CA) and analyzed as previously reported
(Zariwala et al., 2001; Knowles et al., 2012). Mutation profiling of RSPH4A identified
biallelic mutations in 8 unrelated families (10 subjects) without known consanguinity (Table
1). This included four mutant alleles, of which three were novel (Table 1, Supp. Figure S1)
and all are reported to the mutation specific database (www.lovd.nl/RSPH4A). Interestingly,
one of the novel alleles (c.921+3_6delAAGT) was seen in a homozygous state in 6 families
(8 subjects), all of whom were of Hispanic ethnicity from Puerto Rico. Another individual
(#501–1623) of Hispanic ethnicity was compound heterozygous for the identical c.
921+3_6delAAGT mutation and the novel c.1732_1733delG mutation (Supp. Figure S1).
Two unrelated individuals (#668–2033, #235–1147) of non-Hispanic descent (White)
carried a novel c.116C>A mutation on one allele, and #668–2033 carried the known c.
1162+2_5del mutation on the other allele (Zietkiewicz et al 2011). Despite full gene
sequencing, the second mutant allele was not identified on #235–1147 which could be due to
(1) the presence of a large deletion not identified by the Sanger sequencing, (2) deep intronic
mutation affecting splicing that would require transcript analysis, or (3) the presence of
biallelic mutations in another gene. Segregation analysis in all 8 families with biallelic
mutations was consistent with recessive inheritance (Supp. Figure S2). It is pertinent to
mention that screening for mutations in RSPH4A has not been completed for; hence, the
fraction of PCD patients carrying mutation in this gene has not been calculated.
The functional significance of the splice-site mutation c.921+3_6delAAGT at intron 2 was
assessed by studies of RNA splicing. Lymphoblastoid cell lines from carrying mutation were
grown, harvested and subjected to reverse transcriptase-PCR (RT-PCR) as reported
previously (Knowles et al., 2012). Gene specific primers (Supp. Table S2) were designed to
encompass region of mutation and cyclophilin was used as a housekeeping control for
amplification to demonstrate the integrity of the cDNA (Knowles et al., 2013).
Amplification and sequencing conditions were same as described previously (Knowles et al.,
2012).
Analysis from an individual (#135–853) who is homozygous for c.921+3_6delAAGT
mutation revealed an out-of-frame deletion of exon 2 (r.687_921del) leading to a premature
translation termination signal (Supp. Figure S3).
All ten individuals with biallelic mutations in RSPH4A, including Hispanic c.
921+3_6delAAGT homozygotes, had situs solitus (Table 1), which is congruent with other
PCD patients reported to have radial spoke head mutations in RSPH4A and RSPH9, and
defects of the central apparatus in a subset of motile cilia (Castleman et al., 2009; Stannard
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et al., 2004; Zietkiewicz et al., 2012). The lack of laterality defects is presumed to reflect the
fact that the 9+0 embryological nodal cilia is unaffected by the central apparatus defects
seen in RSPH4A mutations; thus, normal lateralization during embryogenesis is preserved
(Papon et al., 2010; Zariwala et al., 2013; Zariwala et al., 2007).
The clinical phenotypes in our patients with biallelic mutations in RSPH4A were similar to
PCD patients with “classic” dynein arm defects, including a high prevalence of neonatal
respiratory distress, otitis media, sinusitis, and bronchiectasis, as well as low nNO (mean
20.6 nl/min; range 10 to 42.7 nl/min) (Noone et al., 2004; Zariwala et al., 2013).
Additionally, the clinical phenotype of our patients with RSPH4A mutations are also
compatible with previously reported patients carrying RSPH4A (RSPH9) loss-of-function
mutations, including seven UK-Pakistani families, and 4 Eastern-European (Polish) families
with PCD, i.e. these patients had chronic oto-sino-pulmonary disease beginning early in life
(Castleman et al., 2009) (Zietkiewicz et al., 2012).
Quantitative ciliary ultrastructural analysis of our patients with biallelic mutations in
RSPH4A were particularly interesting, as ~50% of the cilia had normal ultrastructure (Figure
1A), which is much lower than seen in normal subjects (>85%) (Papon et al., 2010). In the ~
50% of cilia with central apparatus defects, the most common abnormality was absence of
the central pair (Figure 1B + 1C) (18% of cilia) with complete absence in 9% and electron
dense material in the central region in 9%. Translocation of an outer doublet into the central
region, with (Figure 1D) or without a central pair (Figure 1E), being present was seen in
12% of ciliary cross sections. Less common abnormalities included a single microtubule in
place of the central pair (Figure 1F) (5%), eccentric ring of outer doublets (3%), off-center
central pair (Figure 1G) (3%), multiple extra microtubules in the center of the cilia with a
normal central pair (Figure 1I + 1J) (6%), and multiple single microtubules outside the ring
of outer doublets (Figure 1K) (1%). Other findings included 8 outer doublets without a
central pair or translocation (Figure 1L) and 8 outer doublets with 4 single microtubules or 2
doublets in the center (2%). Taken together, the prevalence of central apparatus defects in
patients with RSPH4A mutations (50%) is much greater than seen in normal cilia from
normal subject (<15%) (Papon et al., 2010).
We assessed ciliary beat frequency (CBF) and waveform by high-speed videomicroscopy at
room temperature in nasal epithelial samples from six individuals with biallelic mutations in
RSPH4A (Zhou et al., 2009). The mean CBF was slightly lower (4.7 Hz +/− 1.2) than
normal (7.3 Hz +/− 0.3) from multiple measurements in 10 random fields. However, there
were focal regions with much slower CBF. Similar abnormalities were seen in waveform
and dyskinesia in samples from all six subjects. When the cilia were viewed from a lateral
perspective, there was a decrease in the range of motion, compared to normal, and a lack of
coordinated movement (dyskinesis) with adjacent cilia (Supp. Videos S1 and S2). When
viewed from the top, the cilia exhibited “rotational” movement (Supp. Videos S2 and S3).
These abnormalities have been reported by others in studies of patients with ultrastructural
defects in the central apparatus, and mutations in radial spoke head genes (Castleman et al.,
2009; Chilvers et al., 2003; Stannard et al., 2004; Zietkiewicz et al., 2012). With intact
dynein arms, the velocity of the cilia is less affected by the central apparatus defect; instead,
the cilia waveform mirrors the circular movement seen in nodal cilia, which also lack the
central apparatus.
All individuals carrying the c.921+3_6delAAGT mutation identified themselves as Hispanic
ethnicity from Puerto Rico. Detailed family history did not reveal any known parental
consanguinity. Before the discovery and colonization of the Caribbean by Spanish
Explorers, the Taíno Indians inhabited Hispaniola, Puerto Rico, and the eastern portion of
Cuba (Lalueza-Fox et al., 2001). European colonization and the African slave trade resulted
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in a genetic admixture reflecting Taíno Indian, European, and African American ancestry.
Mitochondrial DNA analysis confirmed the historical records and discovered that the
predominant maternal ancestry in Puerto Rico traces to the Taíno Indians (61.3%)
(Martinez-Cruzado et al., 2005). The geographic isolation of the island of Puerto Rico has
permitted Taíno ancestry to be very prevalent, which may select for rare recessive disorders
like PCD. Thus, the c.921+3_6delAAGT splice site mutation in RSPH4A is likely a Taíno
Indian mutation, rather than a Hispanic mutation from the Spanish colonization. This is
supported by the segregation analysis for patient #501–1623, a compound heterozygote,
with segregation of the c.921+3_6del mutation to the maternal ancestry from Puerto Rico,
while her father identifies as White (non-Hispanic).
In summary, the c.921+3_6delAAGT splice site mutation in RSPH4A is a founder mutation
that is a common cause of PCD without situs abnormalities in patients of Hispanic Puerto
Rican descent. The functional consequences of this splice site mutation reflect full loss-of-
function in respiratory cilia, based on the RNA splice defect leading to a premature
termination signal. Clinical features of respiratory disease and low nNO are also similar to
that seen in patients with “classic” dynein arm defects. This splice site mutation is also
associated with similar defects in ciliary ultrastructure and abnormal ciliary beat frequency
and waveform, as reported in other PCD patients with ultrastructural abnormalities of the
central apparatus and loss-of-function mutations in RSPH4A. Genetic testing for this founder
mutation is warranted to assess for PCD in patients who identify as Hispanic, particularly
those from Puerto Rico, with clinical features consistent with PCD but without situs
abnormalities.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Electron Micrographs Findings
A total of 871 ciliary cross sections were scored from 7 PCD families (8 subjects) with
biallelic mutations in RSPH4A, and representative images are shown. (A) Normal axonemal
structure including central apparatus [9+2] (50% of cilia images); (B) Complete absence of
the central apparatus [9+0] (9% of cilia images) or (C) electron dense material in central
area [9+0] (9% of cilia images); (D) Translocation of outer doublet to replace the central
pair [8+1] (11% of cilia images); (E) Translocation of outer doublet into central region
[8+4] (1% of cilia images); (F) A single microtubule in the center instead of a central pair
[9+1] (5% of cilia images); (G) Eccentric 9 outer doublets with 9+2 arrangement (3% of
cilia images); (H) Central pair off-center with 9+2 arrangement (3% cilia images); (I, J)
Extra singlet or multiple microtubules in center of the cilia (6% of cilia images); (K)
Multiple single microtubules outside the 9 outer doublet ring (1% of cilia images); (L) Other
abnormalities includes 8 outer doublets with or without a normal central apparatus; 7 outer
doublets with a central pair and 2 single microtubules in the center; 8 outer doublets with 2
central pairs; 8 outer doublets with 4 central single microtubules; 8 outer doublets without a
central pair and 1 doublet outside of the outer ring (2% of cilia images).
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